
Buy Crystagen Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy Crystagen Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
Verify Batch
Lot-level COA, Batch DF/CRY/062026
What is Crystagen?
Crystagen is a short peptide from the Russian bioregulator research program, part of the same family as Epithalon and Vilon. It is studied in animal research for its effects on thymic and immune-cell signaling.
- A short peptide studied for its effects on thymic and immune-system tissue
- Part of the Russian organ-targeted bioregulator research program
- Studied in animal research for its effects on immune-cell signaling
- Investigated alongside Epithalon and Vilon from the same program
For research use only. Not approved for human therapeutic use.
Crystagen is a synthetic tripeptide bioregulator with the sequence Glu-Asp-Pro (EDP), corresponding to the molecular formula C₁₄H₂₁N₃O₈ and a free-acid molecular weight of approximately 359.33 g/mol. It belongs to the Khavinson family of ultrashort peptide bioregulators developed at the Saint Petersburg Institute of Bioregulation and Gerontology. EDP is one of the active short-peptide constituents of the thymus-derived polypeptide complex Thymalin. Produced via solid-phase peptide synthesis, Crystagen is classified as an immune-system (thymic) bioregulator.
In preclinical research models, Crystagen is studied for its capacity to modulate immune-cell activity. In a study of immunoprotective peptide activity in the ageing spleen, Crystagen was reported — alongside the related peptides Vilon, Thymogen and R-1 — to activate the B-cell arm of the immune system; unlike Thymogen, however, Crystagen did not restore spleen cell-renewal capacity in aged tissue [1]. At the mechanistic level, and consistent with the proposed direct-to-DNA mode of action, fluorescently labelled peptides of this ultrashort class penetrate the cell nucleus and bind genomic DNA in a sequence-selective manner, providing a structural basis for peptide-directed modulation of tissue-specific gene expression [2]. Within the immune compartment, EDP-type thymic peptides are studied for effects on thymocyte differentiation and proliferation and on macrophage cytokine output, including in aged models where thymic involution is examined, making Crystagen a reference compound in preclinical immunology research examining thymic function, macrophage activation, and age-related immune decline.
Crystagen is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 11 August 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Research
Khavinson Bioregulators: Investigations on Short Peptide Research
Select Size
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis available on this page; MSDS available on request.






